Free Trial

KORU Medical Systems, Inc. (NASDAQ:KRMD) Short Interest Update

KORU Medical Systems logo with Medical background

KORU Medical Systems, Inc. (NASDAQ:KRMD - Get Free Report) was the target of a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 457,400 shares, an increase of 122.6% from the September 15th total of 205,500 shares. Currently, 1.1% of the company's shares are short sold. Based on an average daily trading volume, of 65,600 shares, the days-to-cover ratio is currently 7.0 days.

Analyst Upgrades and Downgrades

KRMD has been the subject of several research analyst reports. B. Riley began coverage on shares of KORU Medical Systems in a research report on Thursday, July 25th. They issued a "buy" rating and a $4.00 target price on the stock. Piper Sandler upped their price objective on shares of KORU Medical Systems from $2.50 to $3.00 and gave the stock an "overweight" rating in a report on Thursday, August 8th.

View Our Latest Analysis on KORU Medical Systems

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Lakewood Asset Management LLC grew its holdings in KORU Medical Systems by 13.9% during the 2nd quarter. Lakewood Asset Management LLC now owns 68,225 shares of the company's stock valued at $181,000 after buying an additional 8,300 shares in the last quarter. Aaron Wealth Advisors LLC purchased a new position in KORU Medical Systems during the second quarter valued at $28,000. Allspring Global Investments Holdings LLC bought a new stake in KORU Medical Systems in the 2nd quarter valued at $28,000. Legato Capital Management LLC purchased a new stake in KORU Medical Systems in the 2nd quarter worth $35,000. Finally, Advisor Resource Council purchased a new stake in KORU Medical Systems in the 1st quarter worth $63,000. Institutional investors own 58.60% of the company's stock.

KORU Medical Systems Stock Performance

NASDAQ:KRMD traded up $0.13 during trading hours on Friday, reaching $2.72. The company had a trading volume of 22,707 shares, compared to its average volume of 122,518. The firm has a market cap of $124.71 million, a price-to-earnings ratio of -10.88 and a beta of 0.42. KORU Medical Systems has a 52 week low of $1.98 and a 52 week high of $3.09. The company has a current ratio of 3.77, a quick ratio of 3.27 and a debt-to-equity ratio of 0.01. The firm's 50 day moving average price is $2.47 and its 200-day moving average price is $2.39.

KORU Medical Systems (NASDAQ:KRMD - Get Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.04) by $0.02. KORU Medical Systems had a negative net margin of 38.16% and a negative return on equity of 20.82%. The firm had revenue of $8.43 million during the quarter, compared to the consensus estimate of $7.52 million. During the same quarter in the previous year, the firm posted ($0.05) EPS. On average, analysts forecast that KORU Medical Systems will post -0.13 EPS for the current year.

KORU Medical Systems Company Profile

(Get Free Report)

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in KORU Medical Systems right now?

Before you consider KORU Medical Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KORU Medical Systems wasn't on the list.

While KORU Medical Systems currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Tesla Stock Rockets 15% Post-Earnings

Tesla Stock Rockets 15% Post-Earnings

Will Tesla's rally continue, or is this the time to lock in gains? See how Thomas Hughes suggests playing the market in this exciting post-earnings period.

Related Videos

Tesla Stock: Profits vs. Price—Is It Time to Sell?
Top Stocks to Buy, Sell, and Hold Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines